Technology transfer is one of the most critical stages of pharmaceutical development. Whether transferring a process within the same manufacturing site or to a CDMO, maintaining a single source of truth while ensuring consistency, quality, and regulatory compliance remains a significant challenge.
Successful technology transfer requires far more than the handover of documentation. It demands that the receiving team has the knowledge, context, and operational understanding needed to execute the transfer efficiently. Yet many organisations continue to rely on fragmented paper and electronic documentation (known as paper on glass), creating inefficiencies, increasing risk, and limiting visibility throughout the transfer lifecycle.
Join this expert panel as industry leaders share practical strategies for overcoming common technology transfer challenges.
Discover how pharmaceutical companies and their manufacturing partners can reduce compliance risks and accelerate time to market by:
• Identifying the critical processes, knowledge, documentation, and data needed to enable successful execution from day one.
• Understanding why establishing a robust quality agreement early which clearly defines responsibilities for change control, deviations, investigations, and batch disposition, is essential for a successful transfer.
• Learning how structured risk assessments can identify potential process vulnerabilities, such as yield loss, mixing parameters, shear stress, and scale-up challenges, enabling proactive mitigation before engineering and validation runs.
• Exploring how digital technologies can replace fragmented paper on glass processes to improve traceability and knowledge transfer